Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)

Publication | Open Access

DOI Full Paper Access

227

Citations

References

2016

Year

René Westhovens, Peter C. Taylor, Rieke Alten, Favio Enríquez-Sosa, Minodora Mazur, Maria Greenwald, Annegret Van der Aa, Frédéric Vanhoutte, Chantal Tasset, Pille Harrison

Annals of the Rheumatic Diseases

Abstract

References